Pharmaceutical Information |
Drug Name |
Griseofulvin |
Drug ID |
BADD_D01042 |
Description |
An antifungal antibiotic. Griseofulvin may be given by mouth in the treatment of tinea infections. |
Indications and Usage |
For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by Trichophyton or Microsporum fungi. |
Marketing Status |
approved; investigational; vet_approved |
ATC Code |
D01AA08; D01BA01 |
DrugBank ID |
DB00400
|
KEGG ID |
D00209
|
MeSH ID |
D006118
|
PubChem ID |
441140
|
TTD Drug ID |
D0C1SF
|
NDC Product Code |
0781-5514; 23155-865; 60264-310; 0472-0013; 42794-012; 62135-494; 64980-184; 0713-0850; 49452-3363; 23155-864; 62135-496; 64980-185; 62135-495; 64980-186; 71052-109; 0781-5515 |
UNII |
32HRV3E3D5
|
Synonyms |
Griseofulvin | Grisefuline | Gris-PEG | Gris PEG | GrisPEG | Grisactin | Fulvicin-U-F | Fulvicin U F | FulvicinUF | Grifulvin V |
|
Chemical Information |
Molecular Formula |
C17H17ClO6 |
CAS Registry Number |
126-07-8 |
SMILES |
CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|